Molecular Testing and Implications for Adjuvant Therapy in Early Stage NSCLC
Dr. Charu Aggarwal, MD, MPH and Dr. John Kucharczuk, MD
Scroll to Continue
Lumakras (Sotorasib) in combination with Vectibix (Panitumumab) FDA Approved for Metastatic Colorectal Cancer with KRAS G12C Mutation
CODEBreaK 300 study demonstrated combination more than doubled progression-free survival compared to physician’s choice of standard of care
High-Risk Prostate Cancer: Study Highlights Role of Advanced Imaging
Advanced imaging technique called PSMA-PET more sensitive at detecting cancer spread in high-risk hormone-sensitive prostate cancer
